Targeted radioactive infusion for late-stage prostate cancer shown to improve outcomes for patients in earlier stages

A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup